Evogene Ltd (EVGN) Live Share Price, Invest From India

Evogene Ltd Stock Performance

as on January 21, 2026 at 8:31 pm IST

Day's Low
$1.01
Day's Price Range
$1.02
$1.02
0.98%
Downside
52 Week's Low
52 Week's High
$0.93
52-Week Price Range
$2.42
$1.02
8.82%
Downside
137.25%
Upside

Evogene Ltd share price movements today

Previous Close: $1.01
Open: $1.01
Volume: 7.4K
Day's Low - High: $1.01 - $1.02
52 Week Low - High: $0.93 - $2.42

Evogene Ltd Historical Returns

1 Month Return: -0.97 %
3 Month Return: -22.31 %
1 Year Return: -44.2 %
3 Year Return: -87.78 %
5 Year Return: -98.38 %

Evogene Ltd Stock Fundamentals & Key Indicators

Check Evogene Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.7M

EPS (TTM)

-0.62

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.6M

Revenue (TTM)

8.0M

Profit Margin

-34.29%

Return On Equity TTM

-70.63%

Evogene Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evogene Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Evogene Ltd	BUY	$9.7M	-98.38%	NA	-34.29%
Alnylam Pharmaceuticals, Inc.	BUY	$47.4B	113.21%	1237.91	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$113.2B	85.25%	31.06	31.35%
Beone Medicines Ltd	NA	$37.4B	NA	663.12	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$77.7B	37.03%	17.57	32.13%

Stock Returns calculator for Evogene Ltd Stock including INR - Dollar returns

The Evogene Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Evogene Ltd investment value today

Current value as on today

₹62,387

Returns

₹37,613

(-37.61%)

Returns from Evogene Ltd Stock

₹43,646 (-43.65%)

Dollar Returns*

₹6,033 (+6.03%)

Analyst Recommendation on Evogene Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evogene Ltd. Average target price of $2.5

Evogene Ltd Share Price Target

Get share price movements and forecasts by analysts on Evogene Ltd.

What analysts predicted

59.2%UPSIDE

Target Price

$2.5

Current Price

$1.02

Analyzed by

8 Analysts

Target

$2.50

Evogene Ltd target price $2.5, a slight upside of 59.2% compared to current price of $1.02. According to 8 analysts rating.

Evogene Ltd Stock’s Investor Sentiment and Interest

Search interest for Evogene Ltd Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: December 22, 2025 to January 21, 2026

Change:43% versus previous 30 day period

Evogene Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	3	0	4	0	1	1	2	0	0
Gross Profit	0	2	0	3	0	0	0	0	0	0
Operating Income	-7	-4	-7	-3	-4	-5	-4	-4	-3	-2
EBITDA	-6	-3	-6	-3	-4	-3	0	-1	-2	-1
Interest Expense	0	0	0	0	0	2	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-3	-7	-3	-4	-6	0	-2	-3	-2
Income Tax Expense	0	0	0	0	0	0	0	-	0	0
Net Income	-7	-3	-6	-3	-5	-7	0	-2	-4	3
Net Profit Margin	-1073.85%	-105.76%	-1142.04%	-92.20%	-895.70%	-438.51%	26.51%	-105.85%	-504.75%	1241.67%

Evogene Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	6	3	1	0	1	0	1	5	8
Gross Profit	1	0	-1	-1	-2	-2	-2	-1	1	3
Operating Income	-17	-21	-21	-21	-22	-26	-31	-29	-26	-21
EBITDA	-14	-17	-18	-18	-15	-23	-27	-26	-23	-15
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	2	2	2	2	2	2	2	2
Income Before Tax	-17	-19	-20	-20	-19	-26	-30	-29	-25	-18
Income Tax Expense	-2	0	0	0	0	0	0	0	0	0
Net Income	-17	-19	-20	-20	-18	-23	-27	-26	-23	-16
Net Profit Margin	-154.67%	-299.57%	-616.33%	-1188.21%	-2405.31%	-2247.50%	-2988.49%	-1590.33%	-423.39%	-193.69%

Evogene Ltd Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-3	-6	-3	-5	-8	0	-2	-3	-4
Operating Cash Flow	-4	-5	-4	-5	-4	-5	-5	-7	-3
Investing Cash Flow	3	0	-4	3	2	8	-2	0	11
Financing Cash Flow	7	0	0	0	4	0	0	4	-10
Change in Cash	7	-6	-8	-2	1	3	-7	0	-2

Evogene Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-20	-20	-19	-26	-30	-29	-25	-18
Operating Cash Flow	-11	-15	-15	-17	-19	-24	-23	-21	-19
Investing Cash Flow	4	15	17	37	9	-20	13	-4	9
Financing Cash Flow	0	0	0	9	20	30	9	18	4
Change in Cash	-6	0	2	28	11	-13	-3	-8	-5

Global Institutional Holdings in Evogene Ltd

Funds	Holdings
Federation des caisses Desjardins du Quebec	0.01%
Tradewinds Capital Management, LLC	0%
Royal Bank of Canada	0%
U.S. Bancorp	0%
Synergy Financial Management, LLC	0%

See all

Insights on Evogene Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -4.46M → 3.87M (in $), with an average increase of 215.2% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 97.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 113.3%
NEGATIVE IMPACT
Price Dip
In the last 3 years, EVGN stock has moved down by -87.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.44M → 312.0K (in $), with an average decrease of 64.3% per quarter

About Evogene Ltd

evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch

Organisation	Evogene Ltd
Headquarters	13 Gad Feinstein Street, Rehovot, Israel, 7638517
Industry	Health Technology
CEO	Mr. Ofer Haviv CPA
E-voting on shares	Click here to vote

Key Management of Evogene Ltd

Name	Title
Mr. Russ Putland	Executive VP Commercial & General Manager USA
Ms. Polina Ravzin	Vice President of Finance
Ms. Liat Foigel Wejgman	Vice President of Human Resources
Dr. Elran Hillel Haber M.B.A., Ph.D.	Chief Executive Officer of Biomica Ltd
Mr. Yoash Zohar	Chief Executive Officer of Casterra Ag Ltd.
Dr. Dan Jacob Gelvan Ph.D.	Chief Executive Officer of Ag Plenus Ltd.
Mr. Amit Noam Capt. res.	Chief Executive Officer of Lavie Bio Ltd.
Mr. Yaron Eldad	Chief Financial Officer
Mr. Ofer Haviv CPA	CEO, President & Director

FAQs

What is Evogene Ltd share price today?

Evogene Ltd share price today is $1.02 as on January 21, 2026 at 8:31 pm IST. Evogene Ltd share today touched a day high of $1.02 and a low of $1.01.

What is the 52 week high and 52 week low for Evogene Ltd share?

Evogene Ltd share touched a 52 week high of $2.42 on June 10, 2025 and a 52 week low of $0.93 on December 30, 2025. Evogene Ltd stock price today i.e. January 21, 2026 at 8:31 pm IST is trending at $1.02,which is 57.85% down from its 52 week high and 9.68% up from its 52 week low.

What is Evogene Ltd's market capitalisation today?

Evogene Ltd market capitalisation is $0.00T as on January 21, 2026 at 8:31 pm IST.

How to invest in Evogene Ltd Stock (EVGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evogene Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evogene Ltd Shares that will get you 1.4706 shares as per Evogene Ltd share price of $1.02 per share as on January 21, 2026 at 8:31 pm IST.

What is the minimum amount required to buy Evogene Ltd Stock (EVGN) from India?

Indian investors can start investing in Evogene Ltd (EVGN) shares with as little as ₹91.673 or $1 (as of January 21, 2026 at 8:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Evogene Ltd stock (as per the Rupee-Dollar exchange rate as on January 21, 2026 at 8:38 pm IST). Based on Evogene Ltd share’s latest price of $1.02 as on January 21, 2026 at 8:31 pm IST, you will get 9.8039 shares of Evogene Ltd. Learn more about fractional shares .

What are the returns that Evogene Ltd has given to Indian investors in the last 5 years?

Evogene Ltd stock has given -98.38% share price returns and 24.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?